4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0000950170-25-112077
Options or other derivatives
- CEO & EXECUTIVE CHAIRMAN acquired 4,800,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Reich Samuel J CEO & EXECUTIVE CHAIRMAN | 2025-08-26 | Grant or award · Stock Option (right to buy) | +4,800,000 | 4,800,000 | D | ||
Loading xslF345X05/ownership.xml…